Health Care Checkup

August 1, 2025

Scheduling Note: The Health Care Checkup will be paused while Congress is in August recess. The next edition will be on Friday, September 5. We hope you have a great August!


THE BIG PICTURE: KEY CONGRESSIONAL & EXECUTIVE BRANCH DEVELOPMENTS


On Tuesday, the Senate voted to confirm Susan Monarez as director of the Centers for Disease Control and Prevention (CDC) in a 51-47 vote. Monarez, an infectious disease researcher, served in senior positions under Democratic and Republican Administrations.


On Thursday, the Senate Appropriations Committee held a markup on the Fiscal Year (FY) 2026 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, advancing it in a 26-3 vote.


On Wednesday, the Senate Health, Education, Labor, and Pensions (HELP) Committee held a markup advancing four healthcare bills: the Over-the-Counter Monograph Drug User Fee Amendments (S.2292), the Uniformed Services Leave Parity Act (S.1440), the Improving Care in Rural America Reauthorization Act (S.2301), and the Kay Hagan Tick Reauthorization Act (S.2398).


On Thursday, President Trump wrote a letter to leading pharmaceutical manufacturers stating that the Trump Administration is enforcing the executive order, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, aimed at aligning U.S. prescription drug prices with those paid in other developed countries.


On Thursday, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that updates Medicare payment policies and rates for inpatient and long-term care hospitals under the Medicare hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) final rule for fiscal year (FY) 2026. The final rule would increase payments to hospitals for inpatient care by $5 billion and increase payments to hospitals with a high amount of charity care by $2 billion. 

What to Expect Next Week:



The Senate may stay in session through the weekend and into next week to continue processing nominations and Fiscal Year 2026 appropriations bills, but the schedule remains in flux. When the Senate does recess, it will return to session on Tuesday, September 2.


The House has been in recess and will also return to session on Tuesday, September 2.

DEEP DIVE

Congressional:


Senate Confirms Susan Monarez to Lead CDC

On Tuesday, the Senate voted to confirm Susan Monarez as Director of the Centers for Disease Control and Prevention (CDC) in a 51-47 vote. Monarez, an infectious disease researcher, served in government positions under Administrations from both parties. She was the Deputy Director of the Advanced Research Projects Agency for Health (ARPA-H) under President Joe Biden and Deputy Assistant Secretary for Strategy and Analysis at the Department of Homeland Security (DHS) during the first Trump Administration.


Senate Appropriations Committee Advances Fiscal Year 2026 Labor-HHS Bill

On Thursday, the Senate Appropriations Committee held a markup on the Fiscal Year (FY) 2026 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, advancing it in a 26-3 vote. The Labor-HHS bill, as amended, would provide about $197 billion in discretionary funding for the departments of Labor, Education and Health and Human Services. Senators Bill Hagerty (R-TN), Christopher Murphy (D-CT), and Tim Kaine (D-VA) voted against the bill. Chair Susan Collins (R-ME) praised the proposed increases to biomedical research and continued funding for programs like the Low-Income Home Energy Assistance Program. The Senate bill would provide the Health and Human Services (HHS) Department with $116.6 billion in discretionary spending, an increase of $446 million over the enacted level and about $22 billion over the White House budget request. The $400 million proposed increase is slated for cancer, Alzheimer's disease, and ALS research. The bill would also provide $48.7 billion for the National Institutes of Health (NIH) and include language that would prevent NIH from capping "indirect" costs on research grants. Notably, the bill did not include funding for the Administration for a Healthy America (AHA), a new agency that would consolidate programming across SAMHSA, HRSA, the Office of the Assistant Secretary for Health, National Institute for Occupational Safety and Health, and the Agency for Toxic Substances and Disease Registry. Read the bill summary here.


Senate HELP Committee Advances Over-the-Counter Drug, Rural Health Bills

On Wednesday, the Senate Health, Education, Labor, and Pensions (HELP) Committee held a markup advancing four healthcare bills. The Committee advanced by voice vote the Over-the-Counter Monograph Drug User Fee Amendments (S.2292), which would reauthorize and amend the Food and Drug Administration's over-the-counter user fee drug program. The bill would also update the existing law to include new reporting requirements for the agency, including how many OTC monograph orders it grants each year and the timeline for granting them. The HELP Committee also advanced the Uniformed Services Leave Parity Act (S.1440), the Improving Care in Rural America Reauthorization Act (S.2301), and the Kay Hagan Tick Reauthorization Act (S.2398), all in a unanimous 23-0 vote. See the bill’s section-by-section and vote results here.


Senate HELP Committee Holds Hearing on Healthcare Affordability

On Thursday, the Senate Health, Education, Labor, and Pensions (HELP) Committee held a hearing examining healthcare affordability in the U.S. During the hearing, Republicans focused on reducing healthcare costs by reforming employer-sponsored insurance, PBMs, and the 340B program, expanding price transparency, addressing fraud, and addressing inefficiencies that drive inflation. Democrats supported the Medicare Drug Price Negotiation Program, opposed Medicaid cuts, criticized hidden costs such as facility fees and administrative waste, and emphasized the importance of transparency and accountability for controlling costs and improving care quality. Members expressed bipartisan support for greater price transparency and the Patients Deserve Price Tags Act, led by Senators Marshall and Hickenlooper, expressed concern about PBM consolidation and rising health care costs, and agreed on the need for reforms to improve affordability and competition. Witnesses stressed the necessity of transparency and accountability in healthcare and warned against the negative impacts of consolidation and high administrative costs on competition and affordability. Read Mehlman’s hearing summary here.


House and Senate Democrats Investigate Vaccine Committee Firings

On Tuesday, Senator Bernie Sanders (I-VT), Ranking Member of the Senate Committee on Health, Education, Labor, and Pensions (HELP), alongside seven Democratic members of the committee, launched an investigation into Health and Human Services Secretary Robert F. Kennedy, Jr.’s decision to fire all 17 members of the Advisory Committee on Immunization Practices (ACIP). Sanders and the senators request that Kennedy provide information on his decision to fire ACIP’s non-partisan members and replace them, including who else was involved in the decision and how the new members were identified and vetted. The senators also asked for information on his decision to stop recommending the COVID-19 vaccine for children and pregnant women. Read the press release and letter here.


Energy and Commerce Committee Democratic leaders also wrote a series of oversight letters to Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., and Food and Drug Administration (FDA) Commissioner Martin Makary on Tuesday, expressing alarm over their efforts to restrict access to vaccines and requesting more information on the new ACIP members. Read the press release and letter here. 


Notable Bills Introduced:


Senators Rosen, Cornyn Introduce Bill to Lower Out-of-Pocket Prescription Drug Costs for Seniors

On Thursday, Senators Jacky Rosen (D-NV) and John Cornyn (R-TX) introduced a bipartisan bill to reduce prescription drug costs for seniors. The Reducing Drug Prices for Seniors Act would directly reduce out-of-pocket costs by requiring that coinsurance payments for prescription drugs for seniors on Medicare be determined based on the lower net price of the medication as opposed to the higher list price. Read the press release here and the bill here.

 

Senators Husted, Hassan, Lead Bipartisan Bill to Expand Access to Safe Medicines

On Wednesday, Senators Jon Husted (R-OH) and Maggie Hassan (D-NH) introduced the Streamlined Market Access and Reform for Therapeutics Over-the-Counter (SMART OTC) Act, which would modernize the Food and Drug Administration’s (FDA) process for giving certain prescription drugs status as over-the-counter (OTC) options. Read the press release here and the bill here.


Representatives Wasserman Schultz, Miller-Meeks, Schrier, Buchanan Introduce Bipartisan Legislation to Expand Genetic Cancer Testing

On Monday, Representatives Debbie Wasserman Schultz (D-FL), Mariannette Miller-Meeks (R-IA), Kim Schrier (D-WA), and Vern Buchanan (R-FL) announced the reintroduction of the Reducing Hereditary Cancer Act. The legislation would remove barriers that block Medicare beneficiaries from accessing heritable cancer screens and medically necessary, guideline-recommended screening and preventative interventions. Read the press release here and the bill here.


Senators Bennet, Blackburn, & Representatives Estes, DelBene Introduce Bill to Support Lifesaving Emergency Services in Rural Communities

On Tuesday, Senators Michael Bennet (D-CO) and Marsha Blackburn (R-TN), alongside Representatives Ron Estes (R-KS) and Suzan DelBene (D-WA), reintroduced the Protecting Air Ambulance Services for Americans Act to improve access to emergency air medical services, particularly in rural communities. The bipartisan, bicameral legislation would utilize data collected under the No Surprises Act to update Medicare reimbursement rates for emergency air services. Read the press release here and the bill here.


Representative Joyce Introduces Bipartisan Legislation to Support Physicians Serving Rural Communities

Late last week, Representative John Joyce, M.D. (R-PA), and Representative Deborah Ross (D-NC) introduced the Specialty Physicians Advancing Rural Care (SPARC) Act. This legislation would create a student loan repayment program for specialty physicians who practice in rural areas. Read the press release here and the bill here.

 

Executive Branch:


President Trump Announces Actions for Drugmakers to Abide by Most-Favored-Nation Pricing on Prescription Drugs

On Thursday, President Trump wrote a letter to leading pharmaceutical manufacturers stating that the Trump Administration is enforcing the executive order, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, aimed at aligning U.S. prescription drug prices with those paid in other developed countries. The letter states that brand-name drug prices in the U.S. are often significantly higher than abroad and outlines four actions the pharmaceutical manufacturers are expected to take within 60 days: extend Most-Favored-Nation (MFN) pricing to all Medicaid patients, guarantee MFN pricing for newly launched drugs across Medicare, Medicaid, and commercial payers, return increased foreign revenues to lower drug costs for Americans, and support direct purchasing models that apply MFN pricing to consumers. President Trump requested the binding commitments by September 29, 2025, and indicated that the Administration will use policy and enforcement tools if these steps are not implemented. Read the fact sheet here.


White House, Tech Leaders Commit to Creating Patient-Centric Healthcare Ecosystem

On Wednesday, the White House hosted a “Make Health Tech Great Again” event with the Centers for Medicare & Medicaid Services (CMS) to unveil voluntary criteria for data exchanges between health information networks, electronic health records, and tech platforms. The initiative would focus on promoting a CMS "interoperability framework" to share information between patients and providers, as well as increasing the availability of personalized tools for patients. Over 60 companies pledged to work with the government on the initiative as early as the first quarter of 2026, including Amazon, Anthropic, Apple, Google, and OpenAI. The Administration’s efforts focus on two broad areas: promoting a CMS Interoperability Framework to easily and seamlessly share information between patients and providers and increasing the availability of personalized tools to assist patients with diabetes and obesity management, replacing paper intake forms with digital check-ins and AI assistants to help patients navigate their care. "For too long, patients in this country have been burdened with a healthcare system that has not kept pace with the disruptive innovations that have transformed nearly every other sector of our economy," CMS Administrator Mehmet Oz said in a statement. Read the CMS press release here.


CMS Releases FY 2026 Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) Final Rule

On Thursday, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that updates Medicare payment policies and rates for inpatient and long-term care hospitals under the Medicare hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) final rule for fiscal year (FY) 2026. The final rule increases IPPS operating payments by 2.6% and LTCH standard payments by 2.7%, increasing hospital payments by $5 billion more for hospitals and $72 million more for LTCHs compared to FY 2025. The rule also phases out the low wage index hospital policy per a court ruling while adopting a transitional payment exception for significantly impacted hospitals, updates quality reporting programs including removing several Social Determinants of Health and health equity measures, codifies updates to Extraordinary Circumstances Exception (ECE) policies, and finalizes changes to the Promoting Interoperability Program by clarifying EHR reporting requirements and adding new bonus and security measures. CMS also advanced work on digital quality measurement, updated policies for the Hospital Readmissions Reduction, Hospital-Acquired Condition, and Value-Based Purchasing programs, adjusted the LTCH Quality Reporting Program to streamline data collection, and confirmed changes to the mandatory Transforming Episode Accountability Model (TEAM) to improve surgical episode payment accountability and patient care coordination through 2030. Read the fact sheet here.


CMS Releases FY 2026 Skilled Nursing Facility (SNF) Prospective Payment System Final Rule

On Thursday, the Centers for Medicare & Medicaid Services (CMS) issued its final rule updating Medicare payment policies and rates for skilled nursing facilities (SNFs) for FY 2026, increasing SNF PPS payments by 3.2%, an estimated $1.16 billion boost, through market basket and forecast adjustments, minus a productivity cut. For the SNF Quality Reporting Program (QRP), CMS will remove four Social Determinants of Health (SDOH) data elements from the resident assessment form starting October 1, 2025, and revise the reconsideration policy, while summarizing stakeholder feedback on future measures, interoperability, and digital reporting improvements. Read the fact sheet here.

 

CMS Releases 2026 Medicare Part D Bid Information and Part D Premium Stabilization Demonstration Parameters

On Monday, the Centers for Medicare & Medicaid Services (CMS) released preliminary Medicare Part D bid information and updated parameters for the 2026 Part D Premium Stabilization Demonstration to help plan sponsors finalize their 2026 offerings. For 2026, CMS is projecting the average base premium will be $38.99, a slight increase from 2025’s average base premium of $36.78. CMS will also reject standalone prescription drug plan (PDP) bids with significant premium increases or outlier costs. For the second year of the voluntary Premium Stabilization Demonstration, CMS adjusted terms by reducing the uniform premium reduction to $10, raising the annual premium increase limit to $50, and removing narrowed risk corridors to gradually transition back to normal market conditions. Eligible PDP sponsors must confirm participation by August 4, 2025. CMS is expected to release the final average Part D and Medicare Advantage premiums in September. Open enrollment for Medicare begins on October 15. Read the press release here.

CONGRESSIONAL HEARINGS & EVENTS

House & Senate: The House and Senate are in recess and will return to session on Tuesday, September 2. 

ADMINISTRATION ANNOUNCEMENTS

Centers for Medicare & Medicaid Services

Food and Drug Administration

National Institutes of Health

1341 G Street NW
Washington, DC 20005
202-585-0258